FDA Inspection
PlasmaLab International, Inc.PlasmaLab International, Inc. – FDA Inspection, Aug 15, 2019
Record Details
This FDA Inspection record concerns PlasmaLab International, Inc., with an inspection on August 15, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 8cc60775-1b50-43cd-b017-4bcac2e0b183
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099645
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.170(a)Adverse Reaction- Reports of Investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PlasmaLab International, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 15, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 25, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 18, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 20, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 16, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for PlasmaLab International, Inc.
- FDA Inspection 1223537 - 2023-11-15
- FDA Inspection 964870 - 2016-03-25
- FDA Inspection 875439 - 2014-04-18
- FDA Inspection 788083 - 2012-06-20
- FDA Inspection 675235 - 2010-06-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.